

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 5.56691065 |
| 2 | nephron epithelium morphogenesis (GO:0072088) | 5.33059727 |
| 3 | nephron tubule morphogenesis (GO:0072078) | 5.33059727 |
| 4 | regulation of integrin activation (GO:0033623) | 5.27289740 |
| 5 | negative regulation of inclusion body assembly (GO:0090084) | 5.24877530 |
| 6 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 5.18940810 |
| 7 | positive regulation of actin filament depolymerization (GO:0030836) | 5.04283366 |
| 8 | astrocyte differentiation (GO:0048708) | 5.03858675 |
| 9 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 5.02772217 |
| 10 | neuron remodeling (GO:0016322) | 4.90028333 |
| 11 | pattern specification involved in kidney development (GO:0061004) | 4.58869344 |
| 12 | protein refolding (GO:0042026) | 4.50471959 |
| 13 | response to peptidoglycan (GO:0032494) | 4.44378329 |
| 14 | ubiquinone biosynthetic process (GO:0006744) | 4.43595353 |
| 15 | adenine nucleotide transport (GO:0051503) | 4.34259641 |
| 16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.26522066 |
| 17 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.26247470 |
| 18 | neuron fate determination (GO:0048664) | 4.23027383 |
| 19 | purine-containing compound salvage (GO:0043101) | 4.15798757 |
| 20 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.10260811 |
| 21 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.08319190 |
| 22 | purine ribonucleotide transport (GO:0015868) | 4.07824711 |
| 23 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 4.03139536 |
| 24 | radial glial cell differentiation (GO:0060019) | 3.92565866 |
| 25 | ubiquinone metabolic process (GO:0006743) | 3.91811661 |
| 26 | response to muramyl dipeptide (GO:0032495) | 3.89579794 |
| 27 | nephron tubule formation (GO:0072079) | 3.85582129 |
| 28 | response to gravity (GO:0009629) | 3.77274870 |
| 29 | UV protection (GO:0009650) | 3.76797592 |
| 30 | macroautophagy (GO:0016236) | 3.70586754 |
| 31 | ATP synthesis coupled proton transport (GO:0015986) | 3.67007968 |
| 32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.67007968 |
| 33 | protein insertion into membrane (GO:0051205) | 3.65242244 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.60734245 |
| 35 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.60563946 |
| 36 | amyloid precursor protein catabolic process (GO:0042987) | 3.60202438 |
| 37 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.59176161 |
| 38 | nucleoside transport (GO:0015858) | 3.45563573 |
| 39 | quinone biosynthetic process (GO:1901663) | 3.44891103 |
| 40 | gap junction assembly (GO:0016264) | 3.38569367 |
| 41 | platelet aggregation (GO:0070527) | 3.36266131 |
| 42 | regulation of inclusion body assembly (GO:0090083) | 3.36111743 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.35119265 |
| 44 | neuronal stem cell maintenance (GO:0097150) | 3.34474866 |
| 45 | positive regulation of protein depolymerization (GO:1901881) | 3.31909336 |
| 46 | mature B cell differentiation involved in immune response (GO:0002313) | 3.25752978 |
| 47 | oligodendrocyte development (GO:0014003) | 3.24692102 |
| 48 | NAD biosynthetic process (GO:0009435) | 3.22255750 |
| 49 | protein maturation by protein folding (GO:0022417) | 3.21324721 |
| 50 | proteasome assembly (GO:0043248) | 3.20003529 |
| 51 | GDP-mannose metabolic process (GO:0019673) | 3.19437578 |
| 52 | regulation of monocyte differentiation (GO:0045655) | 3.17991670 |
| 53 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.14912212 |
| 54 | purine nucleotide transport (GO:0015865) | 3.14306420 |
| 55 | positive regulation of extracellular matrix organization (GO:1903055) | 3.12354449 |
| 56 | renal tubule morphogenesis (GO:0061333) | 3.07383940 |
| 57 | positive regulation of male gonad development (GO:2000020) | 3.04818818 |
| 58 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.98610416 |
| 59 | response to interferon-beta (GO:0035456) | 2.96642020 |
| 60 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.93320823 |
| 61 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.92908095 |
| 62 | regulation of histone phosphorylation (GO:0033127) | 2.92864353 |
| 63 | galactose catabolic process (GO:0019388) | 2.90864816 |
| 64 | protein kinase C signaling (GO:0070528) | 2.90367725 |
| 65 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.88790884 |
| 66 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.88309046 |
| 67 | regulation of metalloenzyme activity (GO:0048552) | 2.86590190 |
| 68 | telencephalon development (GO:0021537) | 2.84094592 |
| 69 | mitochondrion morphogenesis (GO:0070584) | 2.81196208 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 2.78749987 |
| 71 | positive regulation of vasculogenesis (GO:2001214) | 2.75580654 |
| 72 | negative regulation of B cell apoptotic process (GO:0002903) | 2.73343385 |
| 73 | positive regulation of macrophage differentiation (GO:0045651) | 2.72826755 |
| 74 | cellular response to interferon-beta (GO:0035458) | 2.71436137 |
| 75 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.71394065 |
| 76 | GMP metabolic process (GO:0046037) | 2.71170000 |
| 77 | pinocytosis (GO:0006907) | 2.70953062 |
| 78 | UTP biosynthetic process (GO:0006228) | 2.70664318 |
| 79 | pentose metabolic process (GO:0019321) | 2.69622096 |
| 80 | positive regulation of protein complex disassembly (GO:0043243) | 2.65329405 |
| 81 | heart valve formation (GO:0003188) | 2.65157965 |
| 82 | negative regulation by host of viral transcription (GO:0043922) | 2.64661784 |
| 83 | rRNA catabolic process (GO:0016075) | 2.63384154 |
| 84 | purine nucleobase metabolic process (GO:0006144) | 2.62866147 |
| 85 | positive regulation of mast cell degranulation (GO:0043306) | 2.62649690 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.62649690 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62643690 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62093543 |
| 89 | auditory receptor cell differentiation (GO:0042491) | 2.59603994 |
| 90 | autophagic vacuole fusion (GO:0000046) | 2.58273090 |
| 91 | electron transport chain (GO:0022900) | 2.57882240 |
| 92 | homotypic cell-cell adhesion (GO:0034109) | 2.57377974 |
| 93 | respiratory electron transport chain (GO:0022904) | 2.56192157 |
| 94 | estrogen biosynthetic process (GO:0006703) | 2.55902508 |
| 95 | mature B cell differentiation (GO:0002335) | 2.54650533 |
| 96 | response to misfolded protein (GO:0051788) | 2.50739972 |
| 97 | relaxation of smooth muscle (GO:0044557) | 2.50713129 |
| 98 | negative regulation of viral transcription (GO:0032897) | 2.50141382 |
| 99 | cellular metabolic compound salvage (GO:0043094) | 2.48065652 |
| 100 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.45912262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.50816472 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.64152400 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.94421997 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52174315 |
| 5 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.38318416 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25880626 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.17105610 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.11485730 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05160783 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.96993455 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90234272 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.88423605 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.87163986 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.86756764 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.86373454 |
| 16 | GATA1_19941826_ChIP-Seq_K562_Human | 1.84936223 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79363174 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78934046 |
| 19 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.78874674 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.76640741 |
| 21 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.76131675 |
| 22 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.70576192 |
| 23 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.70516591 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70238007 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70172138 |
| 26 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68208650 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.67883800 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65521716 |
| 29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59548496 |
| 30 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.59270697 |
| 31 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.57760333 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57304673 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54781671 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.53682285 |
| 35 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.53489902 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52935113 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52322111 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51855585 |
| 39 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.50851240 |
| 40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49922888 |
| 41 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.49698641 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.47322876 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47298450 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45181995 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.44739372 |
| 46 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43891264 |
| 47 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.43605083 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42557691 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41932456 |
| 50 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41583260 |
| 51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40049511 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39981817 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39846602 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38262048 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37516305 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36690821 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.36495974 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36295028 |
| 59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.35536490 |
| 60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34486340 |
| 61 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.33354547 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31823950 |
| 63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29409397 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26102490 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25510341 |
| 66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23665414 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23260567 |
| 68 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23018384 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22983228 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22749400 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20310169 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.20001691 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19980324 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19566759 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17278605 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.15690841 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15107640 |
| 78 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11319195 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11261385 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10390769 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09693343 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09500414 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09464349 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08755710 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07468085 |
| 86 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07003465 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06653949 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06028618 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05609040 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05600305 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04410867 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03231546 |
| 93 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.03153022 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03086023 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03067843 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02016876 |
| 97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01793079 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01093702 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00506315 |
| 100 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99781563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.90377185 |
| 2 | MP0009384_cardiac_valve_regurgitation | 3.36167933 |
| 3 | MP0000749_muscle_degeneration | 3.35345753 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 3.08621262 |
| 5 | MP0001545_abnormal_hematopoietic_system | 3.08621262 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.92145031 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.70471846 |
| 8 | MP0002282_abnormal_trachea_morphology | 2.62299135 |
| 9 | MP0005451_abnormal_body_composition | 2.56100169 |
| 10 | MP0003828_pulmonary_edema | 2.55391559 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.54521327 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.49740062 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.43460855 |
| 14 | MP0000465_gastrointestinal_hemorrhage | 2.30990899 |
| 15 | MP0009278_abnormal_bone_marrow | 2.30232955 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.16380988 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.02543262 |
| 18 | MP0008961_abnormal_basal_metabolism | 1.99469962 |
| 19 | MP0000343_altered_response_to | 1.98989762 |
| 20 | MP0004272_abnormal_basement_membrane | 1.93314152 |
| 21 | MP0006054_spinal_hemorrhage | 1.90524456 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 1.83390483 |
| 23 | MP0004142_abnormal_muscle_tone | 1.82010358 |
| 24 | MP0000566_synostosis | 1.77152028 |
| 25 | MP0000751_myopathy | 1.77149558 |
| 26 | MP0004510_myositis | 1.75567719 |
| 27 | MP0005623_abnormal_meninges_morphology | 1.69839572 |
| 28 | MP0003718_maternal_effect | 1.67906784 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.60169180 |
| 30 | MP0005394_taste/olfaction_phenotype | 1.56945165 |
| 31 | MP0005499_abnormal_olfactory_system | 1.56945165 |
| 32 | MP0003315_abnormal_perineum_morphology | 1.54041732 |
| 33 | MP0003436_decreased_susceptibility_to | 1.48003277 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.47100661 |
| 35 | MP0004742_abnormal_vestibular_system | 1.37707077 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.33777368 |
| 37 | MP0001853_heart_inflammation | 1.33619962 |
| 38 | MP0009250_abnormal_appendicular_skeleto | 1.29399579 |
| 39 | MP0000358_abnormal_cell_content/ | 1.27023875 |
| 40 | MP0001542_abnormal_bone_strength | 1.26833287 |
| 41 | MP0003329_amyloid_beta_deposits | 1.20888525 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20417522 |
| 43 | MP0002736_abnormal_nociception_after | 1.19705652 |
| 44 | MP0005165_increased_susceptibility_to | 1.18021741 |
| 45 | MP0006138_congestive_heart_failure | 1.12329875 |
| 46 | MP0003786_premature_aging | 1.12306949 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.10778260 |
| 48 | MP0008789_abnormal_olfactory_epithelium | 1.09110480 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.07376434 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.06046458 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.03757509 |
| 52 | MP0000516_abnormal_urinary_system | 0.99981139 |
| 53 | MP0005367_renal/urinary_system_phenotyp | 0.99981139 |
| 54 | MP0003959_abnormal_lean_body | 0.99628200 |
| 55 | MP0003137_abnormal_impulse_conducting | 0.96325684 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 0.96122254 |
| 57 | MP0008775_abnormal_heart_ventricle | 0.95907585 |
| 58 | MP0001968_abnormal_touch/_nociception | 0.94457862 |
| 59 | MP0001851_eye_inflammation | 0.93507278 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 0.92722813 |
| 61 | MP0003787_abnormal_imprinting | 0.92616669 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 0.91753266 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 0.90772224 |
| 64 | MP0000049_abnormal_middle_ear | 0.90510918 |
| 65 | MP0001984_abnormal_olfaction | 0.87421246 |
| 66 | MP0000747_muscle_weakness | 0.85424833 |
| 67 | MP0002332_abnormal_exercise_endurance | 0.85387549 |
| 68 | MP0005164_abnormal_response_to | 0.83467791 |
| 69 | MP0008995_early_reproductive_senescence | 0.82604457 |
| 70 | MP0010030_abnormal_orbit_morphology | 0.82420876 |
| 71 | MP0000534_abnormal_ureter_morphology | 0.82108870 |
| 72 | MP0000490_abnormal_crypts_of | 0.80942581 |
| 73 | MP0000604_amyloidosis | 0.79500786 |
| 74 | MP0005025_abnormal_response_to | 0.77671466 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.75808587 |
| 76 | MP0009931_abnormal_skin_appearance | 0.74254864 |
| 77 | MP0002419_abnormal_innate_immunity | 0.74188461 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.73783698 |
| 79 | MP0000689_abnormal_spleen_morphology | 0.72280388 |
| 80 | MP0001533_abnormal_skeleton_physiology | 0.72280377 |
| 81 | MP0001835_abnormal_antigen_presentation | 0.71481818 |
| 82 | MP0000249_abnormal_blood_vessel | 0.70596669 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.69290210 |
| 84 | MP0003866_abnormal_defecation | 0.68558987 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.67046296 |
| 86 | MP0008260_abnormal_autophagy | 0.65672258 |
| 87 | MP0009333_abnormal_splenocyte_physiolog | 0.62407929 |
| 88 | MP0001849_ear_inflammation | 0.62127824 |
| 89 | MP0005595_abnormal_vascular_smooth | 0.60348416 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.60282564 |
| 91 | MP0005390_skeleton_phenotype | 0.60116209 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.59137080 |
| 93 | MP0002398_abnormal_bone_marrow | 0.58979325 |
| 94 | MP0005384_cellular_phenotype | 0.58794963 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.58120141 |
| 96 | MP0005330_cardiomyopathy | 0.57401937 |
| 97 | MP0001663_abnormal_digestive_system | 0.56775333 |
| 98 | MP0005023_abnormal_wound_healing | 0.56649378 |
| 99 | MP0002420_abnormal_adaptive_immunity | 0.55102797 |
| 100 | MP0002723_abnormal_immune_serum | 0.55033333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Visual hallucinations (HP:0002367) | 5.68285641 |
| 2 | Focal motor seizures (HP:0011153) | 5.29745935 |
| 3 | 11 pairs of ribs (HP:0000878) | 5.19365352 |
| 4 | Axonal loss (HP:0003447) | 4.23547161 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 3.77737051 |
| 6 | Bronchomalacia (HP:0002780) | 3.69467019 |
| 7 | Chronic otitis media (HP:0000389) | 3.57887967 |
| 8 | Hypoplastic iliac wings (HP:0002866) | 3.57776148 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.47991966 |
| 10 | Male infertility (HP:0003251) | 3.37415686 |
| 11 | Nuclear cataract (HP:0100018) | 3.20850763 |
| 12 | Mesangial abnormality (HP:0001966) | 3.19606962 |
| 13 | Petechiae (HP:0000967) | 3.18416353 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 3.13220694 |
| 15 | Dialeptic seizures (HP:0011146) | 3.13050898 |
| 16 | Progressive hearing impairment (HP:0001730) | 3.04929437 |
| 17 | Glossoptosis (HP:0000162) | 2.98904338 |
| 18 | Delusions (HP:0000746) | 2.98349816 |
| 19 | Absence seizures (HP:0002121) | 2.92635068 |
| 20 | Thin ribs (HP:0000883) | 2.77635177 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.77100460 |
| 22 | Prominent supraorbital ridges (HP:0000336) | 2.75232597 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.67083580 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67083580 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67083580 |
| 26 | Type II lissencephaly (HP:0007260) | 2.62074184 |
| 27 | Mucopolysacchariduria (HP:0008155) | 2.59988008 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59988008 |
| 29 | Xerostomia (HP:0000217) | 2.58363967 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 2.52817521 |
| 31 | Distal lower limb amyotrophy (HP:0008944) | 2.52700863 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.50997844 |
| 33 | Progressive sensorineural hearing impairment (HP:0000408) | 2.49995428 |
| 34 | Upper limb muscle weakness (HP:0003484) | 2.49949474 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.43190752 |
| 36 | Missing ribs (HP:0000921) | 2.42316414 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 2.38339561 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 2.38339561 |
| 39 | Personality changes (HP:0000751) | 2.36704872 |
| 40 | Broad face (HP:0000283) | 2.35171185 |
| 41 | Premature ovarian failure (HP:0008209) | 2.34928961 |
| 42 | Glucose intolerance (HP:0000833) | 2.32491801 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30626687 |
| 44 | Abnormality of skull ossification (HP:0002703) | 2.29001006 |
| 45 | Lower limb amyotrophy (HP:0007210) | 2.28378384 |
| 46 | Testicular atrophy (HP:0000029) | 2.25520185 |
| 47 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.19714333 |
| 48 | Vertebral hypoplasia (HP:0008417) | 2.19714333 |
| 49 | Abnormality of iron homeostasis (HP:0011031) | 2.17876376 |
| 50 | Metaphyseal irregularity (HP:0003025) | 2.17778675 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.17000351 |
| 52 | Increased serum ferritin (HP:0003281) | 2.16148008 |
| 53 | Hypoplastic ilia (HP:0000946) | 2.15899766 |
| 54 | Unsteady gait (HP:0002317) | 2.12368977 |
| 55 | Abnormal number of erythroid precursors (HP:0012131) | 2.12325106 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.11835104 |
| 57 | Neonatal short-limb short stature (HP:0008921) | 2.10526779 |
| 58 | Decreased skull ossification (HP:0004331) | 2.09938407 |
| 59 | Easy fatigability (HP:0003388) | 2.09164033 |
| 60 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.08413095 |
| 61 | Retinal dysplasia (HP:0007973) | 2.08249225 |
| 62 | Ovoid vertebral bodies (HP:0003300) | 2.07961964 |
| 63 | Muscle stiffness (HP:0003552) | 2.07454337 |
| 64 | Diaphragmatic weakness (HP:0009113) | 2.06877097 |
| 65 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05240583 |
| 66 | True hermaphroditism (HP:0010459) | 2.03809094 |
| 67 | Purpura (HP:0000979) | 2.02795218 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.02107072 |
| 69 | Menorrhagia (HP:0000132) | 2.01563845 |
| 70 | Inability to walk (HP:0002540) | 2.01133358 |
| 71 | Rapidly progressive (HP:0003678) | 2.00246518 |
| 72 | Trismus (HP:0000211) | 2.00170903 |
| 73 | Abnormality of the sella turcica (HP:0002679) | 1.98369084 |
| 74 | J-shaped sella turcica (HP:0002680) | 1.95225649 |
| 75 | Progressive inability to walk (HP:0002505) | 1.95018874 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93178561 |
| 77 | Joint stiffness (HP:0001387) | 1.89187677 |
| 78 | Disproportionate short-trunk short stature (HP:0003521) | 1.87915321 |
| 79 | Morphological abnormality of the inner ear (HP:0011390) | 1.87893430 |
| 80 | Reduced antithrombin III activity (HP:0001976) | 1.85961939 |
| 81 | Tracheomalacia (HP:0002779) | 1.85836367 |
| 82 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85719448 |
| 83 | Bradycardia (HP:0001662) | 1.85448833 |
| 84 | Generalized amyotrophy (HP:0003700) | 1.85107552 |
| 85 | Generalized tonic-clonic seizures (HP:0002069) | 1.82831072 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 1.81009693 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.81009693 |
| 88 | Hepatic necrosis (HP:0002605) | 1.80734771 |
| 89 | Renal Fanconi syndrome (HP:0001994) | 1.80606389 |
| 90 | Delayed CNS myelination (HP:0002188) | 1.80409081 |
| 91 | Epistaxis (HP:0000421) | 1.80120604 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78702414 |
| 93 | Psychosis (HP:0000709) | 1.78458937 |
| 94 | Hypertensive crisis (HP:0100735) | 1.77749374 |
| 95 | Limb-girdle muscle atrophy (HP:0003797) | 1.75176979 |
| 96 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70890950 |
| 97 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.70890950 |
| 98 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.69962456 |
| 99 | Neonatal respiratory distress (HP:0002643) | 1.69520174 |
| 100 | Hepatocellular necrosis (HP:0001404) | 1.68746977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK1 | 5.52169924 |
| 2 | TSSK6 | 5.37048695 |
| 3 | TESK1 | 3.74069644 |
| 4 | SCYL2 | 3.12829826 |
| 5 | PNCK | 3.06243592 |
| 6 | TAF1 | 2.98026713 |
| 7 | MST4 | 2.96551338 |
| 8 | MAP2K7 | 2.78295902 |
| 9 | WEE1 | 2.64089014 |
| 10 | VRK2 | 2.57727569 |
| 11 | NME2 | 2.27870643 |
| 12 | MAPKAPK5 | 2.03650663 |
| 13 | STK16 | 1.99022909 |
| 14 | TIE1 | 1.94658211 |
| 15 | LIMK1 | 1.86759143 |
| 16 | MAPK15 | 1.70739972 |
| 17 | MAP3K11 | 1.68195367 |
| 18 | MAP4K2 | 1.65995863 |
| 19 | EPHA2 | 1.62419292 |
| 20 | CAMKK2 | 1.53542159 |
| 21 | IRAK3 | 1.44352197 |
| 22 | MOS | 1.42868389 |
| 23 | LATS2 | 1.38433057 |
| 24 | DAPK2 | 1.27662661 |
| 25 | EPHA3 | 1.20048999 |
| 26 | ICK | 1.17494925 |
| 27 | TESK2 | 1.13392832 |
| 28 | MAP3K1 | 1.10749991 |
| 29 | TAOK3 | 1.08697018 |
| 30 | BRSK2 | 1.06195764 |
| 31 | CDK8 | 1.05482353 |
| 32 | MAP3K12 | 1.01936261 |
| 33 | MAPKAPK3 | 0.98934642 |
| 34 | BCKDK | 0.97549427 |
| 35 | PIM2 | 0.96822067 |
| 36 | CCNB1 | 0.95139383 |
| 37 | PTK2B | 0.94923059 |
| 38 | ARAF | 0.92745464 |
| 39 | MAP2K3 | 0.92691574 |
| 40 | MARK1 | 0.92629579 |
| 41 | TBK1 | 0.92379878 |
| 42 | ABL2 | 0.92051949 |
| 43 | MAP3K6 | 0.88972113 |
| 44 | SMG1 | 0.84192612 |
| 45 | CLK1 | 0.80923053 |
| 46 | DAPK1 | 0.77799239 |
| 47 | LMTK2 | 0.72606121 |
| 48 | ZAK | 0.72226264 |
| 49 | MAP4K1 | 0.71258899 |
| 50 | FES | 0.71104852 |
| 51 | ERBB4 | 0.71038095 |
| 52 | MAP3K9 | 0.69414387 |
| 53 | BRSK1 | 0.66857658 |
| 54 | EPHB1 | 0.65128415 |
| 55 | LRRK2 | 0.63543099 |
| 56 | KDR | 0.61781737 |
| 57 | AURKA | 0.61609064 |
| 58 | PRKD2 | 0.59378980 |
| 59 | PAK4 | 0.58885961 |
| 60 | MUSK | 0.57702908 |
| 61 | TAOK1 | 0.56627124 |
| 62 | ERN1 | 0.55889610 |
| 63 | ZAP70 | 0.55226752 |
| 64 | SIK1 | 0.55052427 |
| 65 | PAK2 | 0.54440580 |
| 66 | MAP2K2 | 0.53551022 |
| 67 | VRK1 | 0.50278888 |
| 68 | MARK3 | 0.49038816 |
| 69 | NEK2 | 0.48569287 |
| 70 | ADRBK2 | 0.45646131 |
| 71 | RPS6KB2 | 0.45578614 |
| 72 | DYRK3 | 0.44861281 |
| 73 | STK10 | 0.43570449 |
| 74 | BUB1 | 0.43427311 |
| 75 | EIF2AK2 | 0.40753673 |
| 76 | TTN | 0.40048491 |
| 77 | PAK1 | 0.39642537 |
| 78 | KSR1 | 0.38094546 |
| 79 | MAPK13 | 0.36648359 |
| 80 | MELK | 0.36332329 |
| 81 | ADRBK1 | 0.36175334 |
| 82 | MAPKAPK2 | 0.35289117 |
| 83 | MST1R | 0.32645986 |
| 84 | TEC | 0.31819852 |
| 85 | TYK2 | 0.31530425 |
| 86 | STK11 | 0.30516579 |
| 87 | HIPK2 | 0.30455950 |
| 88 | PRKG2 | 0.30080140 |
| 89 | MAP2K4 | 0.29934602 |
| 90 | CSF1R | 0.29261912 |
| 91 | ROCK1 | 0.27947935 |
| 92 | PKN1 | 0.27497499 |
| 93 | PRKCI | 0.26943158 |
| 94 | JAK3 | 0.26652103 |
| 95 | TRPM7 | 0.26214739 |
| 96 | TGFBR2 | 0.25697293 |
| 97 | MYLK | 0.24516573 |
| 98 | GRK7 | 0.24081131 |
| 99 | PLK3 | 0.23719256 |
| 100 | MAPK11 | 0.22462357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.37519527 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.38620971 |
| 3 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.92319155 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.62457719 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.61013925 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46601538 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.43055070 |
| 8 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.31317436 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.28500699 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.23558586 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09910683 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84984492 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.81701871 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72198973 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.63145671 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.54450352 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.53767579 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.49789429 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.49445840 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48469291 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.43587269 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.32516078 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.30996394 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.27332117 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25737539 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.25711566 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.25023069 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17797602 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16846896 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.16604324 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13292850 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13124092 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13087491 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10926537 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.06202273 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05274704 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02940580 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98706861 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93638324 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91885549 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91747954 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90440830 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89956846 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 0.87135317 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86189875 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.84160629 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 0.81910988 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 0.81725620 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.81652129 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81104043 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78511770 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73916367 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72829846 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72548335 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.71985790 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69816435 |
| 57 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68023780 |
| 58 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65853993 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.65144303 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63774773 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.63533865 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59752775 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58379123 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56499993 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56469848 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56343260 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.55432967 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54689100 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.52773835 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52160897 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49910622 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.49098727 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47552801 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47506103 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46164657 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45895110 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45303459 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45182900 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.44724055 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44091931 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43800180 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42296122 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.40439507 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40251037 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.40136715 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39895870 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38869465 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37298650 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36779448 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35831863 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34620627 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.33999471 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33760956 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33306463 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.31623067 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31457074 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30999972 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.30912801 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30845929 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30446088 |

